As of Oct 20
| +0.02 / +1.96%|
The 4 analysts offering 12-month price forecasts for Genesis Healthcare Inc have a median target of 2.50, with a high estimate of 7.00 and a low estimate of 1.25. The median estimate represents a +140.38% increase from the last price of 1.04.
The current consensus among 5 polled investment analysts is to Hold stock in Genesis Healthcare Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.